Shareholders Equity: The sum of preferred and common equity items.
Tonix Pharmaceuticals Holding Corp. (TNXP) had Shareholders Equity of $245.15M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$5.39M |
|
$-46.91M |
|
$1.06M |
|
$4.33M |
|
$53.68M |
|
$-48.29M |
|
$1.38M |
|
$-46.91M |
|
$-46.91M |
|
$-46.91M |
|
$-46.91M |
|
$-46.91M |
|
$-46.91M |
|
$-48.29M |
|
$-47.80M |
|
8.51M |
|
8.51M |
|
$-4.28 |
|
$-4.28 |
|
| Balance Sheet Financials | |
$228.88M |
|
$44.46M |
|
$48.30M |
|
$277.17M |
|
$30.84M |
|
-- |
|
$1.18M |
|
$32.02M |
|
$245.15M |
|
$245.03M |
|
|
Shareholders Equity |
$245.15M |
12.79M |
|
| Cash Flow Statement Financials | |
$-99.84M |
|
$-4.53M |
|
$214.53M |
|
$99.68M |
|
$209.81M |
|
$110.13M |
|
$6.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
80.37% |
|
-895.84% |
|
-895.84% |
|
-- |
|
-870.32% |
|
-870.32% |
|
$-103.21M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.18 |
|
0.86 |
|
104.71 |
|
-19.14% |
|
-19.14% |
|
-16.92% |
|
-19.14% |
|
$19.17 |
|
$-12.13 |
|
$-11.73 |
|